StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
35
This month
1
This year
6
Publishing Date
2024 - 04 - 02
1
2024 - 02 - 26
1
2024 - 02 - 05
1
2024 - 01 - 15
1
2024 - 01 - 08
1
2024 - 01 - 04
1
2023 - 11 - 14
1
2023 - 10 - 16
1
2023 - 10 - 09
1
2023 - 07 - 03
1
2023 - 06 - 12
1
2023 - 05 - 30
1
2023 - 05 - 10
1
2023 - 02 - 08
1
2022 - 10 - 19
1
2022 - 09 - 29
1
2022 - 07 - 21
1
2022 - 07 - 18
1
2022 - 07 - 11
1
2022 - 06 - 28
1
2022 - 06 - 22
1
2022 - 05 - 18
1
2022 - 04 - 29
1
2022 - 04 - 05
1
2022 - 04 - 04
1
2022 - 01 - 04
1
2021 - 12 - 09
1
2021 - 11 - 16
1
2021 - 11 - 12
1
2021 - 09 - 20
1
2021 - 09 - 15
1
2021 - 06 - 09
2
2021 - 05 - 27
1
2020 - 12 - 22
1
Sector
Health technology
35
Tags
Acquire
2
Agreement
1
Approval
1
Biotechnology
1
Cancer
2
Candidate
1
Ceo
1
Clinical-trials-phase-iii
1
Conference
2
Diabetes
2
Drug
1
Earnings
1
Europe
2
Events
1
Growth
1
Hormone
1
Hypertension
1
Leo
1
License
1
Market
3
N/a
27
Nash
1
New ceo
1
Partnership
1
Payment
1
Pharma
3
Pharmaceutical
3
Phase 3
1
Presentation
2
Program
1
Report
1
Repurchase
11
Research
2
S
1
Sanofi
1
Technology
1
Therapeutics
3
Treatment
2
Trial
4
Trials
1
Entities
Astrazeneca plc
1
Catalent, inc.
1
Eli lilly and company
1
Glaxosmithkline plc
2
Icon plc
1
Innate pharma s.a.
6
Innate pharma sa
4
Insulet corporation
1
Johnson & johnson
1
Novartis ag
2
Novo nordisk a/s
35
Omega therapeutics inc
1
Sanofi
7
Takeda pharmaceutical company limited
1
Teva pharmaceutical industries ltd
1
Symbols
AAPL
40
ABB
68
ABBV
42
ABLZF
60
ABT
60
AFMD
41
ARVL
160
BDX
68
BNTX
56
CSCO
41
CSIQ
59
DOW
43
DSGX
49
EGAN
40
ERIC
52
EXK
47
FNCTF
307
GE
47
GIB
43
GLAXF
44
GSK
55
HITI
55
HON
103
HUBS
329
IBM
58
IGT
48
IMUX
49
INFY
44
JNJ
199
KALV
51
LLY
111
LTUM
70
MDT
44
MMM
41
MRK
43
MS
220
MSFT
52
MT
41
NOC
43
NVS
52
NVSEF
43
PFE
66
PPRUF
53
PPRUY
53
PSN
46
QTRHF
41
SAP
66
SAPGF
55
SNY
269
SNYNF
218
SRE
65
STN
44
TECH
40
TFX
78
TLRY
52
TMO
84
TNXP
51
TRMB
78
TRU
58
VIAV
60
Exchanges
Nasdaq
12
Nyse
35
Crawled Date
2024 - 04 - 02
1
2024 - 02 - 26
1
2024 - 02 - 05
1
2024 - 01 - 15
1
2024 - 01 - 08
1
2024 - 01 - 04
1
2023 - 11 - 14
1
2023 - 10 - 16
1
2023 - 10 - 09
1
2023 - 07 - 03
1
2023 - 06 - 12
1
2023 - 05 - 30
1
2023 - 05 - 10
1
2023 - 02 - 08
1
2022 - 10 - 19
1
2022 - 09 - 29
1
2022 - 07 - 21
1
2022 - 07 - 18
1
2022 - 07 - 11
1
2022 - 06 - 28
1
2022 - 06 - 22
1
2022 - 05 - 18
1
2022 - 04 - 29
1
2022 - 04 - 05
1
2022 - 04 - 04
1
2022 - 01 - 04
1
2021 - 12 - 09
1
2021 - 11 - 16
1
2021 - 11 - 12
1
2021 - 09 - 20
1
2021 - 09 - 15
1
2021 - 06 - 09
2
2021 - 05 - 27
1
2020 - 12 - 22
1
Crawled Time
00:00
4
00:20
3
01:00
7
02:00
6
03:00
1
04:00
3
04:20
5
05:00
5
06:00
33
07:00
36
07:04
1
08:00
31
09:00
15
10:00
29
11:00
35
11:33
1
12:00
65
12:15
9
12:20
16
12:30
10
13:00
37
13:15
7
13:20
9
13:30
9
14:00
38
14:05
1
14:15
3
14:20
6
14:30
5
15:00
38
15:01
1
15:15
2
15:20
8
15:30
8
16:00
24
16:20
2
17:00
23
17:01
1
18:00
19
19:00
14
20:00
16
20:20
1
21:00
19
21:06
1
22:00
16
23:00
8
Source
www.biospace.com
8
www.globenewswire.com
22
www.prnewswire.com
5
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
NVO
crawled time :
11:00
save search
Novo Nordisk A/S - share repurchase programme
Published:
2024-04-02
(Crawled : 11:00)
- globenewswire.com
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
-2.37%
|
O:
-1.96%
H:
1.3%
C:
1.13%
repurchase
Novo Nordisk A/S - share repurchase programme
Published:
2024-02-26
(Crawled : 11:00)
- globenewswire.com
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
0.87%
|
O:
-0.2%
H:
0.78%
C:
0.24%
repurchase
Novo Nordisk to acquire three fill-finish sites from Novo Holdings A/S in connection with the Catalent, Inc. transaction
Published:
2024-02-05
(Crawled : 11:00)
- globenewswire.com
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
9.53%
|
O:
2.37%
H:
1.9%
C:
1.61%
CTLT
|
$55.8
-0.29%
0.0%
1M
|
Health Technology
|
2.33%
|
O:
8.81%
H:
1.5%
C:
0.86%
acquire
Novo Nordisk A/S - share repurchase programme
Published:
2024-01-15
(Crawled : 11:00)
- globenewswire.com
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
Email alert
Add to watchlist
repurchase
Novo Nordisk A/S - share repurchase programme
Published:
2024-01-08
(Crawled : 11:00)
- globenewswire.com
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
17.5%
|
O:
0.19%
H:
0.34%
C:
0.21%
repurchase
Novo Nordisk enters into research collaborations with Omega Therapeutics and Cellarity on novel treatment approaches for cardiometabolic diseases
Published:
2024-01-04
(Crawled : 11:00)
- globenewswire.com
OMGA
|
$2.42
-5.28%
-5.58%
360K
|
|
-6.23%
|
O:
92.31%
H:
20.0%
C:
1.24%
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
20.18%
|
O:
1.44%
H:
3.68%
C:
2.4%
treatment
research
therapeutics
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published:
2023-11-14
(Crawled : 11:00)
- globenewswire.com
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
23.57%
|
O:
-1.07%
H:
0.09%
C:
-0.5%
Novo Nordisk to acquire ocedurenone for uncontrolled hypertension from KBP Biosciences
Published:
2023-10-16
(Crawled : 11:00)
- globenewswire.com
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
21.92%
|
O:
-0.84%
H:
0.19%
C:
-0.13%
acquire
hypertension
Novo Nordisk A/S - share repurchase programme
Published:
2023-10-09
(Crawled : 11:00)
- globenewswire.com
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
35.18%
|
O:
-1.07%
H:
1.15%
C:
1.02%
repurchase
Novo Nordisk A/S - share repurchase programme
Published:
2023-07-03
(Crawled : 11:00)
- globenewswire.com
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
-23.05%
|
O:
-1.05%
H:
0.0%
C:
-0.44%
repurchase
Novo Nordisk A/S - share repurchase programme
Published:
2023-06-12
(Crawled : 11:00)
- globenewswire.com
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
-21.21%
|
O:
1.35%
H:
0.22%
C:
-0.89%
repurchase
Novo Nordisk A/S - share repurchase programme
Published:
2023-05-30
(Crawled : 11:00)
- globenewswire.com
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
-23.59%
|
O:
-0.72%
H:
0.02%
C:
-1.23%
repurchase
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published:
2023-05-10
(Crawled : 11:00)
- globenewswire.com
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
-26.11%
|
O:
-0.81%
H:
1.55%
C:
1.34%
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published:
2023-02-08
(Crawled : 11:00)
- globenewswire.com
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
-10.79%
|
O:
0.85%
H:
0.09%
C:
-0.85%
Diabetes Therapeutics Market Worth $91+ Billion, Globally, by 2028 at 6+% CAGR | The Insight Partners
Published:
2022-10-19
(Crawled : 11:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
48.61%
|
O:
-1.98%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.16
0.08%
0.0%
1.3M
|
Health Technology
|
3.46%
|
O:
-1.18%
H:
0.56%
C:
-1.11%
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
16.71%
|
O:
-0.38%
H:
0.04%
C:
-1.58%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
20.12%
|
O:
-0.52%
H:
0.06%
C:
-0.75%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-12.16%
|
O:
0.46%
H:
0.0%
C:
0.0%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
26.72%
|
O:
0.96%
H:
0.22%
C:
-0.76%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
12.2%
|
O:
-1.37%
H:
0.0%
C:
0.0%
therapeutics
diabetes
market
Ventus Therapeutics Enters Exclusive Development and License Agreement with Novo Nordisk for NLRP3 Inhibitor Program
Published:
2022-09-29
(Crawled : 11:00)
- biospace.com/
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
25.33%
|
O:
1.05%
H:
0.51%
C:
-0.01%
program
license
therapeutics
agreement
Second Innate Pharma NK Cell Engager Selected by Sanofi as Drug Candidate for Development
Published:
2022-07-21
(Crawled : 11:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
-11.58%
|
O:
-2.38%
H:
0.0%
C:
0.0%
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
9.14%
|
O:
-0.28%
H:
1.56%
C:
1.39%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-10.57%
|
O:
-3.38%
H:
0.0%
C:
0.0%
IPHA
|
$2.4
-0.42%
-0.42%
11K
|
Health Technology
|
-24.68%
|
O:
0.0%
H:
0.0%
C:
-2.56%
pharma
drug
candidate
sanofi
Novo Nordisk A/S – Share repurchase programme
Published:
2022-07-18
(Crawled : 11:00)
- globenewswire.com
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
10.36%
|
O:
1.43%
H:
1.11%
C:
-1.28%
repurchase
Novo Nordisk A/S – Share repurchase programme
Published:
2022-07-11
(Crawled : 11:00)
- globenewswire.com
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
15.54%
|
O:
1.18%
H:
1.24%
C:
0.45%
repurchase
Global Clinical Trials Markets 2022-2028: Globalization of Clinical Trials / Increasing R&D Promoting Outsourcing / Adoption of New Technology in Clinical Research
Published:
2022-06-28
(Crawled : 11:00)
- prnewswire.com
NVO
|
$122.75
-1.43%
0.0%
2.8M
|
Health Technology
|
10.59%
|
O:
-2.98%
H:
0.66%
C:
-0.87%
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
132.0%
|
O:
0.99%
H:
0.0%
C:
0.0%
ICLR
|
$291.74
-0.1%
-0.1%
500K
|
Health Technology
|
32.21%
|
O:
-0.57%
H:
0.96%
C:
-0.24%
trials
research
technology
trial
← Previous
1
2
Next →
Gainers vs Losers
64%
36%
Top 10 Gainers
AGBA
|
News
|
$1.02
155.0%
57.94%
120M
|
Finance
ZCMD
|
$2.86
108.76%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.555
104.6%
51.13%
5M
|
Health Technology
ISPC
|
$0.437
105.16%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
News
|
$0.92
84.0%
45.65%
1.6M
|
OST
|
$0.499
21.38%
45.26%
1.9M
|
XPON
|
News
|
$3.1
60.62%
37.74%
17M
|
TIRX
|
$0.7
44.39%
30.74%
58M
|
BNTC
|
News
|
$6.92
44.17%
30.64%
3.5M
|
Health Technology
GGE
|
$0.035
19.86%
29.3%
64M
|
Your saved searches
Save your searches and get alerts when important news are released.